verve therapeutics lilly - Search News

Order byBest matchMost fresh

News

Eli Lilly nears $1.3B deal for Verve Therapeutics

· 8h · on MSN

Eli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion

Eli Lilly agreed to acquire Verve Therapeutics for about $1 billion upfront, adding a potential treatment for cardiovascular disease to its portfolio.Under the agreement, the pharmaceutical company will buy all of the gene-editing startup’s shares outstanding for $10.

Continue reading

· 7h · on MSN

Eli Lilly Co. to buy gene-editing startup Verve to develop cardiac drugs

· 11h · on MSN

Eli Lilly’s $1.3 Billion Bid Sends Verve Therapeutics Stock Soaring. What to Know.

8h

Eli Lilly Buys Verve Therapeutics: Aims To Permanently Lower Your Cholesterol

Eli Lilly (LLY) will acquire Verve Therapeutics (VERV) for up to $13.5/share, aiming to revolutionize cholesterol treatment.

pharmaphorum12h

Update: Rumour confirmed as Lilly buys Verve Therapeutics

Eli Lilly has confirmed plans for a $1.3 billion takeover bid for Verve Therapeutics, upgrading a collaboration between the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results